Thomas Jefferson University

Iyad Alnahhas

TitleAsst Professor
InstitutionThomas Jefferson University
DepartmentNeurosurgery
Address901 Walnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Carey P, Gardner C, Uppendahl A, Kantor J, Cappelli L, Alnahhas I, Andrews D, Daskalakis C, Shi W. Body mass index as a prognostic indicator of overall survival in glioblastoma: A systematic review and meta analysis. J Clin Neurosci. 2024 Dec 30; 133:111019. PMID: 39740645.
      Citations:    
    2. Alnahhas I. Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice? Curr Oncol Rep. 2024 Oct 03. PMID: 39361075.
      Citations:    
    3. Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, Poiset SJ, Zhan T, Judy KD, Andrews DW, Simone NL, Alnahhas I, Shi W. Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM). J Clin Neurosci. 2024 Jul 27; 127:110754. PMID: 39068727.
      Citations:    
    4. Shi W, Palmer JD, Alnahhas I. Emerging insights on management of high-grade glioma. Chin Clin Oncol. 2024 Jan 17. PMID: 38247720.
      Citations:    
    5. Cappelli L, Khan MM, Kayne A, Poiset S, Miller R, Ali A, Niazi M, Shi W, Alnahhas I. Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial. Chin Clin Oncol. 2023 Jun; 12(3):23. PMID: 37417289.
      Citations:    
    6. Ali AS, Lombardo J, Niazi MZ, Miller RC, Alnahhas I, Martinez NL, Andrews DW, Judy KD, Shi W. Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200?kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study. J Neurooncol. 2022 Nov; 160(2):345-350. PMID: 36355259.
      Citations:    
    7. Miller R, Song A, Ali A, Niazi M, Bar-Ad V, Martinez N, Glass J, Alnahhas I, Andrews D, Judy K, Evans J, Farrell C, Werner-Wasik M, Chervoneva I, Ly M, Palmer J, Liu H, Shi W. Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma. Front Oncol. 2022; 12:896246. PMID: 35574391.
      Citations:    
    8. Song AJ, Ding K, Alnahhas I, Laperriere NJ, Perry J, Mason WP, Winch C, O'Callaghan CJ, Menten JJ, Brandes AA, Phillips C, Fay MF, Nishikawa R, Osoba D, Cairncross JG, Roa W, Wick W, Shi W. Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac011. PMID: 35098127.
      Citations:    
    9. Song AJ, Ding K, Alnahhas I, Laperriere NJ, Perry J, Mason WP, Winch C, O'Callaghan CJ, Menten JJ, Brandes AA, Phillips C, Fay MF, Nishikawa R, Osoba D, Cairncross JG, Roa W, Wick W, Shi W. Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trial. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab153. PMID: 34765975.
      Citations:    
    10. Rayi A, Alnahhas I, Ong S, Giglio P, Puduvalli VK. Targeted Therapy for BRAF Mutant Brain Tumors. Curr Treat Options Oncol. 2021 Oct 06; 22(11):105. PMID: 34613491.
      Citations:    
    11. Rinehardt H, Kassem M, Morgan E, Palettas M, Stephens JA, Suresh A, Ganju A, Lustberg M, Wesolowski R, Sardesai S, Stover D, Vandeusen J, Cherian M, Prieto Eibl MDPG, Miah A, Alnahhas I, Giglio P, Puduvalli VK, Ramaswamy B, Williams N, Noonan AM. Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience. Eur J Breast Health. 2021 Oct; 17(4):371-377. PMID: 34651117.
      Citations:    
    12. Alnahhas I, Rayi A, Guillermo Prieto Eibl MDP, Ong S, Giglio P, Puduvalli V. Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDHwt glioblastoma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab127. PMID: 34667950.
      Citations:    
    13. Alnahhas I, Alsawas M, Rayi A, Palmer JD, Raval R, Ong S, Giglio P, Murad MH, Puduvalli V. Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab095. PMID: 34258581.
      Citations:    
    14. Alnahhas I, LaHaye S, Giglio P, Mardis E, Puduvalli V. An evaluation of MGMT promoter methylation within the methylation subclasses of glioblastoma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa117. PMID: 33880446.
      Citations:    
    15. Alnahhas I, Rayi A, Thomas D, Ong S, Giglio P, Puduvalli V. False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. Am J Clin Oncol. 2020 11; 43(11):802-805. PMID: 32889892.
      Citations:    
    16. Alnahhas I, Alsawas M, Rayi A, Palmer JD, Raval R, Ong S, Giglio P, Murad HM, Puduvalli V. Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa082. PMID: 33150334.
      Citations:    
    17. Alnahhas I, Rayi A, Palmer JD, Raval R, Folefac E, Ong S, Giglio P, Puduvalli V. The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort study. Neurooncol Pract. 2021 Feb; 8(1):75-80. PMID: 33664972.
      Citations:    
    18. Alnahhas I, Rayi A, Ong S, Giglio P, Puduvalli V. Management of gliomas in patients with Lynch Syndrome. Neuro Oncol. 2020 Oct 16. PMID: 33059358.
      Citations:    
    19. Carpenter CD, Alnahhas I, Gonzalez J, Giglio P, Puduvalli VK. Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target. Expert Rev Neurother. 2019 07; 19(7):663-677. PMID: 31106606.
      Citations:    
    20. Fabian D, Guillermo Prieto Eibl MDP, Alnahhas I, Sebastian N, Giglio P, Puduvalli V, Gonzalez J, Palmer JD. Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review. Cancers (Basel). 2019 Feb 02; 11(2). PMID: 30717372.
      Citations:    
    21. Alnahhas I, Jawish M, Alsawas M, Zukas A, Prokop L, Murad MH, Malkin M. Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis. Clin Lymphoma Myeloma Leuk. 2019 03; 19(3):e129-e141. PMID: 30584023.
      Citations:    
    22. Alnahhas I, Wong J. A case of new-onset antibody-positive myasthenia gravis in a patient treated with pembrolizumab for melanoma. Muscle Nerve. 2017 06; 55(6):E25-E26. PMID: 27935080.
      Citations:    
    23. Alnahhas I, Malkin M. Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology. 2015 Dec 15; 85(24):e187-9. PMID: 26668244.
      Citations:    
    24. Alahdab F, Firwana B, Hasan R, Sonbol MB, Fares M, Alnahhas I, Sabouni A, Ferwana M. Undergraduate medical students' perceptions, attitudes, and competencies in evidence-based medicine (EBM), and their understanding of EBM reality in Syria. BMC Res Notes. 2012 Aug 12; 5:431. PMID: 22882872.
      Citations:    
    25. Firwana BM, Hasan R, Hasan N, Alahdab F, Alnahhas I, Hasan S, Varon J. Tumor lysis syndrome: a systematic review of case series and case reports. Postgrad Med. 2012 Mar; 124(2):92-101. PMID: 22437219.
      Citations:    
    Alnahhas's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (56)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _